In the title structure, C22H30S2, L10, the asymmetric unit contains two independent molecules, both of which lie on crystallographic inversion centers, and the aliphatic chains are in the all‐trans conformation. The crystal structure is stabilized by a combination of van der Waals forces and weak C—H⋯π(arene) interactions.
The title compound, trans‐[PdCl2(PhSCH2SPh)2], crystallizes with two half‐molecules in the asymmetric unit and each independent molecule lies about a crystallographic inversion center. In each molecule, one S atom of the bis(phenylsulfanyl)methane ligand is coordinated to the Pd atom while the second S atom of the same ligand is uncoordinated.
In the title crystal structure, C14H14S2, L2, the molecules lie on crystallographic inversion centers. The phenyl rings are nearly perpendicular to the planar S—C—C—S group of atoms.
The title compound, {[Ag(C15H16S2)2]SbF6·0.5C4H10O}n, was obtained from the self‐assembly of AgSbF6 and 1,3‐bis(phenylsulfanyl)propane. Each AgI ion is coordinated by four S atoms from different ligands, forming a distorted tethrahedral geometry. Each ligand links adjacent AgI ions, forming an extended two‐dimensional grid‐like framework. SbF6− ions, which are incorporated into the cavities of the network, complete and stabilize the structure. One of the phenyl rings is disordered over two sites, the ratio of occupancies being 0.508 (4):0.492 (4).
Key indicatorsSingle-crystal X-ray study T = 100 K Mean (C-C) = 0.003 Å R factor = 0.054 wR factor = 0.166 Data-to-parameter ratio = 14.7For details of how these key indicators were automatically derived from the article, see
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.